Side Letter: Is your GP manipulating performance?

An academic report suggests PE firms are more inclined to manipulate portfolio company performance when under pressure to raise their next fund. Plus: Why OPERF isn't deterred by a little overexposure to PE and a French GP is using its management fees to drive impact. Here's today's brief, for our valued subscribers only.